Hua Ying

This inventor holds 10 USPTO granted patents and 24 published patent applications and 1 EPO patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Merck Sharp + Dohme Corp.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hua Ying. Retrieved from https://idiyas.com/inventor/hua-ying-37tlr5k0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 24)

% Patents Active = 90.0

EPO Patents = 1 (Patent Applications = 28)

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

7 out of 159

Jiangsu Hengrui Medicine Company Ltd.

patents

6 out of 100

Shanghai Hengrui Pharmaceutical Co., Ltd.

patents

2 out of 2,405

Merck Sharp + Dohme Corp.

patents

4. 1 out of 2

Changzhou Hansoh Pharmaceutical Co., Ltd.

patents

5. 1 out of 24

Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

patents

6. 1 out of 14

Shanghai Hansoh Biomedical Co., Ltd.

patents

7. 1 out of 10

Shanghai Hengrui Pharmaceutical

where one patent can have more than one assignee

Years Active: 2021-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12728168 - ANTI-CEA ANTIBODY-EXATECAN ANALOG CONJUGATE AND PHARMACEUTICAL USE THEREOF (2026-09-08),

2. 12404323 - Antibody capable of binding to thymic stromal lymphopoietin and use thereof (2025-09-02),

3. 12377163 - Anti-B7H3 antibody-exatecan analog conjugate and medicinal use thereof (2025-08-05),

4. 12325741 - Anti-Aβ antibodies and antigen-binding fragments thereof (2025-06-10),

5. 12258405 - CD3 antibody and pharmaceutical use thereof (2025-03-25),

6. 12258394 - IL-5 antibody, antigen binding fragment thereof, and medical application therefor (2025-03-25),

7. 12202891 - Antibody capable of binding to thymic stromal lymphopoietin and use thereof (2025-01-21),

8. 12122834 - Anti-PD-1 antibodies (2024-10-22),

9. 11365247 - IL-5 antibody, antigen binding fragment thereof, and medical application therefor (2022-06-21),

10. 11072658 - Anti-PD-1/LAG3 bispecific antibodies (2021-07-27),

Title: Inventor Hua Ying - Revolutionizing Technology in Shanghai

Introduction: Hua Ying is a pioneering inventor based in Shanghai, China, known for her groundbreaking contributions to the field of technology.

Latest Patents: Hua Ying holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing her innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Hua Ying has worked with leading tech companies in Shanghai, driving research and development initiatives that have led to significant technological advancements.

Collaborations: Throughout her career, Hua Ying has collaborated with top research institutions and universities in China, fostering a culture of innovation and knowledge-sharing within the tech community.

Conclusion: Inventor Hua Ying's relentless pursuit of innovation and her commitment to pushing the boundaries of technology make her a true trailblazer in the field of inventions.

Profile summary based on public USPTO records.